• <em>Drosophila</em> Contributions towards Understanding Neurofibromatosis 1
• <em>NF1</em>-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of <em>NF1</em>-Mutant Rhabdomyosarcoma and <em>NF1</em>-Associated Malignant Triton Tumor
• A 23-year-female with plexiform neurofibroma type 1: a rare clinical image
• A Comprehensive Overview of NF1 Mutations in Iranian Patients
• A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening
• A Population Pharmacokinetic Assessment of the Effect of Food on Selumetinib in Patients with Neurofibromatosis Type 1-Related Plexiform Neurofibromas and Healthy Volunteers
• A Systematic Review on Visual-Processing Deficits in Neurofibromatosis Type 1: What Possible Impact on Learning to Read?
• Advanced case of Waldenström macroglobulinemia complicated by acquired hemophilia A in a patient with neurofibromatosis type 1
• An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies
• An Uncommon Coexistence of Dural and Intraventricular Meningiomas
• Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study
• Auditory brainstem implant: current states and future prospects
• Autism spectrum disorder profiles in RASopathies: A systematic review
• Brigatinib in <em>NF2</em>-Related Schwannomatosis with Progressive Tumors
• Cardiac screening in pediatric patients with neurofibromatosis type 1: similarities with Noonan syndrome?
• Case of embryonal tumor multilayered rosettes in a patient with neurofibromatosis type 1
• Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss
• Clinical features and surgical treatments of scoliosis in neurofibromatosis type 1: a systemic review and meta-analysis
• Cochlear Implantation in Neurofibromatosis Type 2-Related Schwannomatosis: Long-Term Hearing Outcomes
• Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
• Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors
• Development of moyamoya arteriopathy following treatment of intracranial tumors: clinical and radiographic characterization
• Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1)
• Distinct attentional and executive profiles in neurofibromatosis type 1: Is there difference with primary attention deficit-hyperactivity disorder?
• Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1
• Efficacy and safety of selumetinib in patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: a systematic review and meta-analysis
• Efficacy of Trametinib in Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumors: A Case Report
• Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers
• Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1
• Endoscopic submucosal dissection for a rare cause of esophageal mass: Von Recklinghausen's neurofibromatosis
• Features of course of pain syndrome in patients with schwannomatosis
• Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis
• Free fibula flap to achieve bone union after congenital pseudoarthrosis of the forearm in neurofibromatosis: Technical report based on 3 cases, and literature review
• G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells
• Generation of a human iPSC line CIPi004-A from a patient with neurofibromatosis type 1 and epilepsy harboring a heterozygous mutation in NF1 gene
• Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes
• Genotype-phenotype correlations and treatment innovation of neurofibromatosis type 1 (NF1): Current understanding and perspective
• Giant cell granuloma and neurofibroma in the mandible of a patient with neurofibromatosis type 1: a long-term follow-up case report with radiological and surgical aspects and a review of the literature
• Glial plasticity dysregulation contributes to learning impairments in the neurogenetic disorder NF1
• Guided Growth to Treat Anterolateral Tibial Bowing Associated with Congenital Pseudarthrosis of the Tibia
• Hemoperitoneum secondary to a malignant tumor of the sheath of the peripheral nerve in the liver
• High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity
• Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1)
• Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis
• HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States
• Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1
• Incidence of Ophthalmological Complications in NF-1 Patients Treated with MEK Inhibitors
• Inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1: a case report
• Jaffe-Campanacci syndrome; a case series and review of the literature
• Key features of choroidal abnormalities in neurofibromatosis type 1, a commentary on "Histologic correlates of "choroidal abnormalities" in neurofibromatosis type 1 (NF1)"
• Living in my own skin: dermatological concerns and gender-affirming care as a trans person with neurofibromatosis type 1
• Living with… neurofibromatosis type 1
• MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by <em>NF1</em> loss in Schwann cells and skeletal stem/progenitor cells
• Multimodal Imaging Characteristics and Diagnostic Value of Choroidal Nodules in Patients with Neurofibromatosis Type 1
• Natural history of hearing and tumor growth in vestibular schwannoma in neurofibromatosis type 2-related schwannomatosis
• Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature
• Neurofibromatosis type 1 with huge intrathoracic meningoceles misdiagnosed as pleural effusion: A case report and literature review
• Neurofibromatosis type 2 in the otorhinolaryngological practice
• Neurovascular pathology in a patient with neurofibromatosis type 1. Case report
• NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma
• NF1^+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1-associated cognitive and motor impairment
• NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues
• Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas
• p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs
• Past, Present, and Future Therapeutic Strategies for NF-1-Associated Tumors
• Pathological findings in enucleated eyes of patients with neurofibromatosis type 1: report of a case with 15-year follow-up and review of 14 patients in the literature
• PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas
• Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis
• Phenotypic Expansion of Autosomal Dominant <em>LZTR1</em>-Related Disorders with Special Emphasis on Adult-Onset Features
• Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1
• Plexiform neurofibroma masquerading as a giant congenital melanocytic nevus
• Posterior Transdural Approach for Thoracic Corpectomies in the Setting of Complex Spine Deformity Reconstruction
• Postoperative hyphema due to persistent tunica vasculosa lentis in glaucoma associated with neurofibromatosis-a case report
• Precision oncology in neurofibromatosis type 1: quantification of differential sensitivity to selumetinib in plexiform neurofibromas using single-cell RNA sequencing
• Prenatal diagnosis of familial 17q11.2 duplication encompassing NF1 in a pregnancy associated with asymptomatic carrier parent
• Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex
• Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma
• Reconstruction of congenital pseudarthrosis of the radius with a vascularized tibial periosteal transplant: A case report
• Recurrent spontaneous pneumothorax in an NF1 patient with a novel causative variant: broadening genotype-phenotype correlations
• Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1"
• Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma
• Robotic resection for splenic artery aneurysm associated with neurofibromatosis type 1: a case report
• Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINT
• snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response
• Social cognition in children with neurofibromatosis type 1
• Spatial transcriptomics implicates impaired BMP signaling in NF1 fracture pseudarthrosis in murine and patient tissues
• STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy
• Surgical management of omega deformity in a patient with neurofibromatosis type 1: a case report
• Surgical Treatment Outcomes of Anterior-Only Correction and Reconstruction for Severe Cervical Kyphotic Deformity with Neurofibromatosis-1: A Retrospective Study with a 5-Year Follow-Up
• Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma
• The genetic spectrum of <em>NF1</em> variants in 10 unrelated Chinese families with neurofibromatosis type 1
• The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1
• The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis
• The molecular biology of NF2/Merlin on tumorigenesis and development
• The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands
• Treatment of emotion regulation problems in people with neurofibromatosis type 1
• Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas
• Unruptured giant lateral thoracic meningocele: extremely rare cause of cerebrospinal fluid (CSF) hypotension in neurofibromatosis type 1
• Vesicourachal Diverticulum: An Uncommon Incidental Finding on Staging ¹⁸F-FDG PET/CT in a Patient with Suspected Malignant Transformation of Neurofibromatosis
• Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy